Droseffik 0.02 mg - 3 mg film-coat. tabl.

Land: Belgien

Sprache: Englisch

Quelle: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Wirkstoff:

Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)

Verfügbar ab:

EFFIK Benelux SA-NV

ATC-Code:

G03AA12

INN (Internationale Bezeichnung):

Drospirenone; Ethinylestradiol; Placebo

Dosierung:

0,02 mg - 3 mg

Darreichungsform:

Film-coated tablet

Zusammensetzung:

Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo

Verabreichungsweg:

Oral use

Therapiebereich:

Drospirenone and Ethinylestradiol

Produktbesonderheiten:

CTI code: 428407-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-02 - Pack size: 2 x 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-03 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224122 - CNK code: 2995744 - Delivery mode: Medical prescription; CTI code: 428407-04 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224139 - CNK code: 2995751 - Delivery mode: Medical prescription; CTI code: 428407-05 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224146 - CNK code: 2995769 - Delivery mode: Medical prescription

Berechtigungsstatus:

Commercialised: Yes

Berechtigungsdatum:

2012-10-05